Nanalysis Scientific Competitors

OTC Stocks . USA . 
Stock . Nanalysis Scientific Corp
NSCIF Stock  USD 0.09  -0.01  -5.66%   
The company classifies itself in the Scientific & Technical Instruments industry (Technology sector). Nanalysis Scientific Corp is grouped alongside Quarta Rad, Guerrilla, Signal Advance, and SideChannel within its competitive landscape. Return on equity for Nanalysis Scientific looks different when stacked against the top and bottom of its peer set.

Correlation: Nanalysis Scientific vs SideChannel Summary

Weak diversification
Nanalysis Scientific currently posts a 0.5 correlation with SideChannel, indicating a Weak diversification relationship for the active sample. The overlap area shows the portion of risk that can be diversified away by holding both instruments together.

Moving together with Nanalysis OTC Stock

  0.66HXGBY Hexagon AB ADRPairCorr

Moving against Nanalysis OTC Stock

  0.68KEYS Keysight TechnologiesPairCorr
  0.68COHR Coherent Buyout TrendPairCorr
  0.6GRMN GarminPairCorr
  0.49TDY Teledyne TechnologiesPairCorr
  0.43MKSI MKS InstrumentsPairCorr
Specify up to 10 symbols:
The mean reversion principle applied to Nanalysis Scientific's suggests that neither prolonged outperformance nor underperformance is permanent. Identifying the root cause of Nanalysis Scientific's price dislocation is essential before acting on a mean reversion signal. The mean reversion tendency in Nanalysis Scientific's price is a well-documented phenomenon in academic research. In many cases, Nanalysis Scientific's price extremes present statistical patterns that have recurred historically.
Hype
Prediction
LowEstimatedHigh
0.000.094.97
Details
Intrinsic
Valuation
LowRealHigh
0.000.084.96
Details
Naive
Forecast
LowNextHigh
0.00180.094.97
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.090.110.12
Details
No single-company analysis of Nanalysis Scientific Corp is complete without peer benchmarking. A company that looks attractive in isolation may be significantly outperformed by competitors. Standalone analysis captures Nanalysis Scientific's individual story, but peers reveal if it is truly exceptional. Disciplined peer analysis separates conviction-grade insights from superficial Nanalysis Scientific observations.

Nanalysis Scientific Competition Correlation Matrix

Correlation analysis between Nanalysis Scientific Corp and its competitors provides context for understanding whether diversification is real or only superficial inside the same peer group. The business currently sits in the Technology sector and the Scientific & Technical Instruments industry. In practical terms, lower correlation may offer better diversification while higher correlation may leave the portfolio more exposed to one shared driver.

High positive correlations

PLCKF
+ 0.8
GBUX
GBUX
+ 0.65
YNVYF
ROBOF
+ 0.63
GUER
SDCH
+ 0.58
PLCKF
SDCH
+ 0.57
GBUX
PLCKF
+ 0.56
YNVYF
  

High negative correlations

BNSOF
- 0.4
QURT
QURT
- 0.35
YNVYF
GUER
- 0.31
YNVYF
SIGL
- 0.27
QURT
GBUX
- 0.27
QURT
PLCKF
- 0.25
QURT

Risk-Adjusted Indicators

Strong recent returns in Nanalysis OTC Stock do not always mean Nanalysis Scientific OTC Stock is outperforming peers on business quality. Without risk-adjusted context, investors may overweight short-term returns and underweight the volatility required to achieve them. These indicators are quantitative in nature and help investors evaluate volatility and risk-adjusted expected returns across different positions.

Nanalysis Scientific Competitive Analysis

How does Nanalysis Scientific measure up against Ynvisible Interactive, Quarta Rad, and Jeotex? The financials tell a nuanced story. Nanalysis Scientific operates at a 47.5 M scale with 16.0 M flowing through the income statement. Nanalysis Scientific currently operates at a -30.19% net margin with return on equity at -19.70%, reflecting headwinds in the current cycle. Nanalysis Scientific leads on revenue, 16.0 M to 1.4 M, a substantial gap. On pure scale, Nanalysis Scientific is the larger business with market caps of 47.5 M versus 7.0 M. Market capitalization diverges sharply here: 47.5 M versus 204,960, giving Nanalysis Scientific a clear size advantage.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NSCIF YNVYF QURT GBUX DWDZF PLCKF GUER ROBOF BNSOF SIGL
 5.66 
0.09
Nanalysis
 4.31 
0.08
Ynvisible
 0.00 
0.70
Quarta
 12.00 
0.01
GivBux
 0.00 
0.0001
Jeotex
 1.51 
0.09
Plurilock
 23.53 
2.31
Guerrilla
 0.00 
0.0001
RoboGroup
 12.87 
2.28
Bonso
 11.11 
0.16
Signal
Market Volatility
(90 Days Market Risk)
Stable
Stable
Abnormal
Stable
Very Low
Stable
Extreme
Stable
High
Stable
Market Performance
(90 Days Performance)
Weak
Weak
Mild
Weak
Weak
Weak
Soft
Weak
Soft
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Average
Low
Low
Low
High
Low
Unknown
High
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Over Valued
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
1.94
9.53
1.77
N/A
0.07
1.2
1.6
1.58
N/A
641.12
Net Asset
37.79 M
20.18 M
581.6 K
N/A
5.88 M
18.48 M
10.63 M
N/A
N/A
N/A
Profit Margin
-0.3
N/A
-0.13
N/A
N/A
-0.14
-0.86
-0.0893
N/A
N/A
EBITDA
1.38 M
-5.17 M
13.55 K
N/A
-17.07 M
-6.31 M
-1.91 M
-12 K
N/A
-614.27 K
Operating Margin
-0.28
-9.35
0.0607
N/A
-3.1
-0.12
-0.81
-0.0598
N/A
31.22
Current Valuation
52.82 M
-2.35 M
4.14 M
1.3 M
10.09 M
8.15 M
61.31 M
17.44 M
N/A
469.15 K
Price To Book
1.91
0.66
18.28
0.0899
N/A
2.96
36.38
1.24
N/A
85.47
Retained Earnings
N/A
N/A
N/A
N/A
N/A
N/A
N/A
-10 M
N/A
N/A
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
11 M
N/A
N/A
Beta
0.98
1.27
-1.8
N/A
-1713.19
0.65
N/A
1.08
N/A
-0.0725
Number Of Employees
107
16
2
1
940
6
65
89
N/A
5
Shares Outstanding
94.22 M
124.67 M
15.67 M
N/A
1.22 M
86.78 M
33.72 M
52.51 M
N/A
10.46 M
Cash Flow From Operations
-1.2 M
-4.61 M
54.4 K
N/A
-1.2 M
-2.03 M
-4.82 M
-5.02 M
N/A
-409.75 K
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
144.63
N/A
N/A
Total Debt
2.75 M
201.83 K
N/A
N/A
12.99 M
201.72 K
144.78 K
2.64 M
N/A
3.02 M
Return On Equity
-0.2
-0.33
-0.45
N/A
N/A
-2.13
-13.65
-0.13
N/A
-0.0929
Z Score
10.2
25.8
2.0
N/A
-3.6
37.0
N/A
4.6
N/A
N/A
Return On Asset
-0.0726
-0.23
0.0615
N/A
-0.92
-0.17
-0.68
-0.0261
N/A
-0.0391
Book Value Per Share
0.39
0.12
0.016
N/A
-31.67
0.048
0.044
0.3
N/A
0.18
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
3 M
N/A
N/A
Total Asset
37.79 M
20.18 M
581.6 K
N/A
5.88 M
18.48 M
10.63 M
13 M
N/A
N/A
Debt To Equity
0.16
0.012
N/A
N/A
1.34
0.31
1.1
0.17
N/A
0.39
Shares Owned By Institutions
0.085
1.57
N/A
N/A
0.55
N/A
0.12
N/A
N/A
N/A
Market Capitalization
47.47 M
8.81 M
7.02 M
1.3 M
204.96 K
12.12 M
50.57 M
16.7 M
N/A
2.29 M
Price To Earning
N/A
N/A
58.3
N/A
-0.13
N/A
N/A
N/A
N/A
0.86
Price To Sales
2.3
8.87
4.08
0.0056
0.0617
0.12
4.53
0.83
N/A
2.17
Net Income
-1.77 M
-5.89 M
7.34 K
N/A
-17.24 M
-6.28 M
-2.84 M
-3.07 M
N/A
-620.01 K
Earnings Per Share
-0.033
-0.038
N/A
N/A
-8.76
-0.086
N/A
-0.07
N/A
-0.019
Shares Owned By Insiders
7.37
2.62
97.37
N/A
N/A
5.81
56.52
62.64
N/A
N/A
Revenue
16.04 M
1.38 M
1.25 M
N/A
18.28 M
36.62 M
10.48 M
19.48 M
N/A
-21.96 K
Working Capital
N/A
N/A
N/A
N/A
N/A
N/A
N/A
8 M
N/A
N/A
Cash And Equivalents
12.28 M
13.91 M
342.39 K
N/A
113 K
3.06 M
1.7 M
2.02 M
N/A
10.26 M
Cash Per Share
0.13
0.11
0.02
N/A
0.09
0.04
0.05
0.04
N/A
0.26
Gross Profit
10.24 M
115.38 K
483.08 K
N/A
4.62 M
2.38 M
6.14 M
9.49 M
N/A
-47.6 K
Day Typical Price
0.0856
0.08
0.7
0.0089
1.0E-4
0.0912
2.31
1.0E-4
2.26
0.16
Accumulation Distribution
12834.81
N/A
N/A
3999.1
N/A
546.85
9.52
N/A
0.0219
14.71
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
0.0
N/A
0.05
0.0
Daily Balance Of Power
-0.51
N/A
0.0
-4.00
0.0
-1.27
44.0
0.0
5.2
-2.00
Period Momentum Indicator
-0.01
-0.0036
N/A
-0.0012
N/A
-0.0014
0.44
N/A
0.26
-0.02
Rate Of Daily Change
0.94
0.96
1.0
0.88
1.0
0.98
1.24
1.0
1.13
0.89
Day Median Price
0.0851
0.08
0.7
0.009
1.0E-4
0.091
2.3
1.0E-4
2.26
0.17
Price Action Indicator
-0.001
-0.0018
N/A
-0.0008
N/A
-0.0001
0.23
N/A
0.15
-0.01
Relative Strength Index
26.22
37.28
58.97
38.42
N/A
35.43
52.24
N/A
49.9
42.11
Coefficient Of Variation
-1,942
-1,466
2236.02
-1,048
N/A
-786.15
7635.47
-812.40
13847.48
-4,416
Mean Deviation
2.12
2.11
1.08
9.39
N/A
3.28
4.52
2.95
2.46
5.87
Jensen Alpha
-0.25
-0.26
0.1443
-1.31
N/A
-0.61
0.1258
-1.49
0.0372
-0.18
Total Risk Alpha
0.117
0.0262
0.517
-0.28
N/A
-0.25
0.7353
-0.56
0.3981
0.4519
Sortino Ratio
N/A
N/A
N/A
N/A
N/A
N/A
0.0197
N/A
0.0138
N/A
Downside Variance
N/A
N/A
N/A
N/A
N/A
N/A
66.73
N/A
41.01
N/A
Standard Deviation
4.87
3.87
4.31
15.14
N/A
4.92
8.22
12.19
4.81
8.41
Kurtosis
15.68
4.4
43.22
11.63
N/A
1.23
7.88
66.0
4.33
0.2799
Potential Upside
8.33
7.2
N/A
23.97
N/A
7.69
16.28
N/A
6.51
13.64
Treynor Ratio
-2.75
-1.80
-0.30
-0.63
N/A
-1.61
0.2201
-4.66
0.1257
-0.76
Maximum Drawdown
36.36
27.32
43.65
110.08
N/A
24.88
62.37
99.0
29.88
38.75
Variance
23.7
14.95
18.56
229.12
N/A
24.2
67.52
148.5
23.14
70.65
Market Risk Adjusted Performance
-2.74
-1.79
-0.29
-0.62
N/A
-1.60
0.2301
-4.65
0.1357
-0.75
Risk Adjusted Performance
-0.03
-0.05
0.0447
-0.07
N/A
-0.1
0.0197
-0.09
0.0142
-0.01
Skewness
2.62
0.2773
5.43
2.39
N/A
0.4524
1.47
-8.12
0.6474
-0.31
Semi Deviation
N/A
N/A
N/A
N/A
N/A
N/A
6.24
N/A
3.65
N/A
Information Ratio
-0.04
-0.05
0.0571
-0.09
N/A
-0.12
0.0196
-0.12
0.0183
-0.02
Value At Risk
-8.33
-6.20
N/A
-19.72
N/A
-9.00
-11.06
N/A
-10.13
-16.00
Expected Short fall
N/A
N/A
N/A
N/A
N/A
N/A
-6.32
N/A
-5.12
N/A
Downside Deviation
N/A
N/A
N/A
N/A
N/A
N/A
8.17
N/A
6.4
N/A
Semi Variance
N/A
N/A
N/A
N/A
N/A
N/A
38.95
N/A
13.36
N/A

Nanalysis Scientific Competition Peer Performance Charts

How to Analyze Nanalysis Scientific Against Peers

Nanalysis Scientific's peer analysis compares Nanalysis Scientific with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether Nanalysis Scientific trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where Nanalysis Scientific leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.

Peer Comparison Metrics & Methodology

Nanalysis Scientific has a wider economic moat score than the average competitor, based on return spread and reinvestment patterns. When Nanalysis Scientific and a peer diverge sharply on valuation, the earnings and cash flow data usually explain why. Relative analysis can highlight whether current pricing already reflects peer-group strengths or weaknesses. For peer comparison, Nanalysis Scientific has a market cap of 47.47 M, profit margin of -30.19%.

Reported values for Nanalysis Scientific Corp are derived from periodic company reporting and market reference feeds and then standardized for analysis. Refresh timing depends on source availability.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors
Last reviewed on March 19th, 2026
Macroaxis provides analytical tools and reference data for investors of all levels to evaluate holdings and assess risk across market volatility, economic shifts, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY